Combining local and systemic therapies
HR: 0.79 (CI 0.622–1.02; p=0.058)
in all randomly assigned patients
EORTC 40983
Nordlinger et al: Lancet (2008) 371:1007
Progression free survival after resection +/- FOLFOX4
Clinical results